Continuous digital monitoring of glucose concentration (CGM) dependingof lifestyle in healthy adults and evaluation of the new CGM health metrics
- Conditions
- E11I10-I15Type 2 diabetes mellitusHypertensive diseases
- Registration Number
- DRKS00032597
- Lead Sponsor
- Institut für Klinische Pharmazie und Pharmakotherapie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 6
Inclusion Criteria
Healthy pharmacy students in the 7th semester of pharmacy at the HHU Düsseldorf who voluntarily gave their consent to participate
Exclusion Criteria
Lack of informed consent to participate in the study
Lack of consent to data protection
Diagnosis of diabetes mellitus type 1 or 2
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method CGM metrics: time in target range [70-180 mg/dL], number of hypoglycemias, number of hyperglycemias, glucose exposure (area under the curve), glucose variability<br>long-term blood pressure monitor: data collection
- Secondary Outcome Measures
Name Time Method Knowledge development on the topic of digital health”<br>Satisfaction & experience with the CGM system or long-term blood pressure monitor, quality of life while wearing the systems